Phase II study of first-line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma (HCC) Meeting Abstract
| Authors: | Abou-Alfa, G. K.; Blanc, J. F.; Miles, S.; Ganten, T. M.; Trojan, J.; Cebon, J. S.; Liem, A. K. D.; Lipton, L. R.; Gupta, C.; Wu, B.; Litten, J. B.; Saltz, L. |
| Abstract Title: | Phase II study of first-line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma (HCC) |
| Meeting Title: | 2014 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2014 Jan 16-18 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-01-20 |
| Language: | English |
| ACCESSION: | WOS:000333682100288 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.3_suppl.286 |
| Notes: | Meeting Abstract: 286 -- Gastrointestinal Cancers Symposium -- JAN 16-18, 2014 -- San Francisco, CA -- S -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
